Please login to the form below

Not currently logged in
Email:
Password:

Michael J Fox Foundation

This page shows the latest Michael J Fox Foundation news and features for those working in and with pharma, biotech and healthcare.

Pfizer joins up with IBM for internet-of-things collaboration

Pfizer joins up with IBM for internet-of-things collaboration

Wearables have piqued the industry's interest in Parkinson's, with UCB beginning trials of a wearable sensor in December, the Michael J Fox Foundation backing a different trial earlier this

Latest news

  • Michael J Fox Foundation backs wearable device trial Michael J Fox Foundation backs wearable device trial

    Michael J Fox Foundation backs wearable device trial. Partners with chip manufacturer Intel and Cynapsus Therapeutics on Parkinson's study. ... Trials of a new therapy for Parkinson's disease developed by Cynapsus Therapeutics will use a smartwatch-like

  • UCB trials wearable sensor for Parkinson's UCB trials wearable sensor for Parkinson's

    Earlier this year the Michael J Fox Foundation, which funded the first web-based system to remotely access data from 'miniature sensors attached to the body' in 2008, tied up with ... The Michael J Fox Foundation also collaborated with biotech Sage

  • Another $2m donated to further neurodegenerative commitment Another $2m donated to further neurodegenerative commitment

    Fox Foundation for Parkinson's Research in the US, the Weston Brain Institute in Canada and Alzheimer's Research UK, which joins as the programme makes a second round of research ... Fox Foundation, added: “ A collaboration such as BAND promotes

  • Charity coalition pledges millions for brain disease research Charity coalition pledges millions for brain disease research

    Neuro– MAP's partners are Alzheimer's Association US, Alzheimer Research UK, Alzheimer's Society UK, ALS Association, Michael J Fox Foundation, MND Association, MRC Technology, Northern Health Science Alliance and

  • Roche signs Parkinson's deal with Prothena Roche signs Parkinson's deal with Prothena

    deal with Amicus Therapeutics, and Lundbeck, which has received funding from Parkinson's charity the Michael J Fox Foundation.

More from news
Approximately 2 fully matching, plus 9 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics